Abbott Laboratories ROE 2006-2018 | ABT

Current and historical return on equity (ROE) values for Abbott Laboratories (ABT) over the last 10 years.
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.003B $27.390B
Abbott is a global healthcare company devoted to improving life through the development of products and technologies that span the breadth of healthcare. They have a portfolio of leading, science-based offerings in diagnostics, medical devices, nutritionals and branded generic pharmaceuticals.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $118.964B 18.41
Stryker (SYK) United States $64.929B 25.97
Boston Scientific (BSX) United States $46.555B 25.95
Baxter (BAX) United States $40.001B 28.62
Zimmer Biomet Holdings (ZBH) United States $22.844B 14.39
ResMed (RMD) United States $15.490B 32.39
Smith & Nephew SNATS (SNN) United Kingdom $15.465B 0.00
Perrigo (PRGO) Ireland $10.581B 14.84
Bio-Rad Laboratories (BIO) United States $9.046B 72.96
Hill-Rom Holdings (HRC) United States $6.207B 22.30
ICU Medical (ICUI) United States $6.175B 57.46
Canopy Growth (CGC) Canada $5.749B 0.00
Agios Pharmaceuticals (AGIO) United States $5.297B 0.00
Insulet (PODD) United States $5.208B 0.00
Haemonetics (HAE) United States $5.062B 52.13
Hutchison China MediTech (HCM) China $4.438B 0.00
Neogen (NEOG) United States $4.224B 67.54
GW Pharmaceuticals (GWPH) United Kingdom $4.134B 0.00
National Vision Holdings (EYE) United States $3.060B 0.00
NuVasive (NUVA) United States $2.724B 27.53
Quidel (QDEL) United States $2.634B 115.26
Phibro Animal Health (PAHC) United States $1.934B 28.71
Abaxis,Inc (ABAX) United States $1.905B 64.07
NxStage Medical (NXTM) United States $1.857B 0.00
VAREX IMAGING (VREX) United States $1.424B 21.94
Eagle Pharmaceuticals (EGRX) United States $1.224B 34.22
Cardiovascular Systems (CSII) United States $1.172B 0.00
Orthofix (OFIX) $1.095B 33.36
Owens & Minor (OMI) United States $1.066B 10.71
OraSure Technologies (OSUR) United States $1.019B 61.81
AtriCure (ATRC) United States $1.017B 0.00
Omeros (OMER) United States $0.968B 0.00
Cerus (CERS) United States $0.960B 0.00
MacroGenics (MGNX) United States $0.920B 0.00
TG Therapeutics (TGTX) United States $0.893B 0.00
Surmodics (SRDX) United States $0.786B 134.66
LeMaitre Vascular (LMAT) United States $0.710B 41.78
Meridian Bioscience (VIVO) United States $0.661B 23.28
PetIQ (PETQ) United States $0.634B 0.00
Insys Therapeutics (INSY) United States $0.602B 0.00
Lantheus Holdings (LNTH) United States $0.528B 13.80
Evolus (EOLS) United States $0.504B 0.00
Surface Oncology (SURF) United States $0.407B 0.00
Utah Medical Products (UTMD) United States $0.364B 24.09
Cytosorbents (CTSO) United States $0.356B 0.00
Quanterix (QTRX) United States $0.324B 0.00
NanoString Technologies (NSTG) United States $0.316B 0.00
BioLife Solutions (BLFS) United States $0.285B 0.00
Rockwell Medical (RMTI) United States $0.225B 0.00
Chimerix (CMRX) United States $0.220B 0.00
Fonar (FONR) United States $0.171B 10.36
Bovie Medical (BVX) United States $0.168B 0.00
Chembio Diagnostics (CEMI) United States $0.158B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.131B 0.00
Female Health (VERU) United States $0.113B 0.00
Trinity Biotech (TRIB) Ireland $0.105B 31.25
Oramed Pharmaceuticals (ORMP) Israel $0.098B 0.00
United-Guardian (UG) United States $0.089B 20.91
Neurotrope (NTRP) United States $0.085B 0.00
InfuSystems Holdings (INFU) United States $0.075B 0.00
CAS Medical Systems (CASM) United States $0.056B 0.00
Imprimis Pharmaceuticals (IMMY) United States $0.049B 0.00
Capricor Therapeutics (CAPR) United States $0.039B 0.00
ImmuCell (ICCC) United States $0.039B 0.00
Valeritas Holdings (VLRX) United States $0.037B 0.00
Akers Biosciences Inc (AKER) United States $0.035B 0.00
Myomo (MYO) United States $0.030B 0.00
Senestech (SNES) United States $0.025B 0.00
Cellectar Biosciences (CLRB) United States $0.012B 0.00
NeuroMetrix (NURO) United States $0.011B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.003B 0.00